As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at one noteworthy recent insider buy.
On Monday, Director Matthew Strobeck bought $152,000 worth of Accelerate Diagnostics (NASDAQ:AXDX), buying 8,000 shares at a cost of $19.00 a piece. Before this latest buy, Strobeck made one other purchase in the past twelve months, buying $230,400 shares for a cost of $11.52 each. Accelerate Diagnostics is trading up about 3.5% on the day Wednesday. Strobeck was up about 30.8% on the buy at the high point of today's trading session, with AXDX trading as high as $24.85 at last check today.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.